Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000262301 | SCV000338965 | uncertain significance | not provided | 2016-02-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000262301 | SCV002141095 | uncertain significance | not provided | 2022-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 747 of the TRIM37 protein (p.Asn747Ser). This variant is present in population databases (rs143613788, gnomAD 0.09%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with TRIM37-related conditions. ClinVar contains an entry for this variant (Variation ID: 285792). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV000262301 | SCV004224414 | uncertain significance | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | BP4 |
Laboratory of Diagnostic Genome Analysis, |
RCV000262301 | SCV001797457 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000262301 | SCV001966223 | likely benign | not provided | no assertion criteria provided | clinical testing |